Skip to content

The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men

The Effect of Mixed Exercise and Metabolic Stress Upon Pituitary Secretion in Relationship to Age in Healthy Men: a Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01800370
Enrollment
40
Registered
2013-02-27
Start date
2013-02-28
Completion date
2014-04-30
Last updated
2014-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy, Male

Brief summary

Aging in men reduces the amount of luteinizing hormone (LH) and testosterone (Te) secreted in each burst. Stress-associated mechanisms introduced by acute illness and chronic disease decrease LH and Te secretion further. A major unresolved issue is whether the aging process heightens the negative effects of a stressor (whether physical or metabolic) upon LH and Te secretion. This study will assess LH and Te secretion in response to a physical stressor (maximal exercise) and a common metabolic stressor (hyperglycemia) as a function of age in healthy men ages 18-80 yr.

Interventions

DRUGHyperglycemia

Hyperglycemia (rest controlled) will be induced by i.v. injection of 25 mL of dextrose 50% over 3 minutes with the subject supine.

DRUGSaline

Saline (rest controlled) will be induced by i.v. injection of 25 mL of saline over 3 minutes with the subject supine.

OTHERExercise

Monitored exercise of 7-minute biking, 2-minute arm weights and a blood draw at the 10-minute time point will be repeated 3 times,which takes 30 minutes. Bilateral arm curls begin at 20 pounds and decrease by 5 pounds as needed to sustain 2 minutes of exercise at a rate of 1 complete curl every 2 seconds.

PROCEDUREBlood Draws

Blood will be sampled every 10 min from 0700 to 1300 h. Each intervention will begin at 0800 h after 1 h of baseline sampling, and be completed by 0900 h. Intervention is followed by 4 additional h of sampling to capture recovery (total sampling 6 h). Ten-min samples are for Te, LH, ACTH, cortisol, and GH. Glucose will be checked every 30 min. At 07000 h an archival serum sample will be obtained for safety-monitoring purposes.

OTHERFasting procedure

Beginning at 1900 h on the evening prior to each study visit, subjects will remain fasting except for water, diet soda, and other non-caloric and non-caffeinated fluids, until 1300 h the next day.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Community dwelling, healthy men age 18 to 80 * Body-Mass Index (BMI) 18-30 kg/m2 * Willingness to provide written informed consent * Physician acceptable screening ECG for participants 60 years and older

Exclusion criteria

* recent use of psychotropic or neuroactive drugs (within five biological half-live) * obesity (outside weight range above) * acute weight change (loss or gain of \>2 kg in 6 weeks * Laboratory test results not deemed physician acceptable * triglycerides \> 300 * BUN \>30 * creatinine \> 1.5 mg/dL * liver functions tests twice upper limit of normal * electrolyte abnormality * anemia; hemoglobin \< 12.0 gm/dL * drug or alcohol abuse * psychosis, depression, mania or severe anxiety * acute or chronic organ-system disease * endocrinopathy, other than primary thyroidal failure receiving replacement * untreated osteoporosis * nightshift work or recent transmeridian travel (exceeding 3 time zones within 7 days of admission) * PSA \> 4.0 ng/mL, History or suspicion of prostatic disease (elevated PSA,indeterminate nodule or mass, obstructive uropathy) * History of carcinoma (excluding localized basal cell carcinoma removed or surgically treated with no recurrence * History of thrombotic arterial disease (stroke, TIA, MI, angina) or deep vein thrombophlebitis * History of CHF, cardiac arrhythmias, congential QT prolongation, and medications used to treat cardiac arrhythmias * Gynecomastia \> 2 cm, untreated * Untreated gallbladder disease * History of smoking greater than one ppd.

Design outcomes

Primary

MeasureTime frameDescription
Change in Testosterone concentration after 30 minutes of exercise30 minutes after initiating exerciseDuring the exercise visit subjects will perform an exercise test on a bike and lift weights with both arms for a total of 30 minutes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026